CoChat

Amitriptyline versus placebo for major depressive disorder

Leucht, Claudia, Huhn, Maximilian, Leucht, Stefan · 2011 · Cochrane Database of Systematic Reviews
Cited by 53

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: 1. To determine the efficacy of amitriptyline in comparison with placebo for alleviating the acute symptoms of major depressive disorder. 2. To investigate the acceptability of amitriptyline in comparison with placebo for major depressive disorder. 3. To investigate the adverse effects of amitriptyline in comparison with placebo for people with major depressive disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd009138

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 30

  1. 1980, Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM III)
  2. 1987, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition - Revised (DSM-III-R)
  3. 1994, Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV)
  4. Barbui, 2000, Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002791 · DOI · Paper page
  5. Barbui, 2008, Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials, Canadian Medical Association Journal, 178, 296, 10.1503/cmaj.070693 · DOI · Paper page
  6. Berger, 2004, Psychische Erkrankungen. Klinik und Therapie
  7. Davis, 1993, A quantitative analysis of clinical drug trials for the treatment of affective disorders, Psychopharmacology Bulletin, 29, 175
  8. Der-Simonian, 1986, Meta-analysis in clinical trials, Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  9. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 13, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  10. Feighner, 1972, Diagnostic criteria for use in psychiatric research, Archives of General Psychiatry, 26, 57, 10.1001/archpsyc.1972.01750190059011 · DOI · Paper page
  11. Furukawa, 2003, Low dosage tricyclic antidepressants for depression, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003197 · DOI · Paper page
  12. Gayetot, 2007, [When depression does not end. Resistant depression: recent clinical and therapeutic aspects], Review Medical de Liege, 62, 103
  13. Greenberg, 1992, A meta-analysis of antidepressant outcome under "blinder" conditions, Journal of Consulting and Clinical Psychology, 60, 664, 10.1037/0022-006X.60.5.664 · DOI · Paper page
  14. Guaiana, 2007, Amitriptyline versus other types of pharmacotherapy for depression, Cochrane Database of Systematic Reviews
  15. Guy, 1976, Clinical Global Impressions - ECDEU Asessment Manual Psychopharmacology (DHEW Publ No ADM 76-338)
  16. Hamilton, 1960, A rating scale of depression, Journal of Neurology, 23, 56
  17. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  18. Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org 2008 · DOI · Paper page
  19. Kawakami, 2007, Epidemiology of depressive disorders in Japan and the world, Nippon Rinsho, 65, 1578
  20. Leucht, 2007, Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs, Neuropsychopharmacology, 32, 1903, 10.1038/sj.npp.1301325 · DOI · Paper page
  21. Lohse, 2009, Psychopharmaka, 820, 10.1007/978-3-642-01080-4_39 · DOI
  22. Luborsky, 1962, Clinician's judgments of mental health, Archives of General Psychiatry, 7, 407, 10.1001/archpsyc.1962.01720060019002 · DOI · Paper page
  23. Montgomery, 1979, A new depression scale designed to be sensitive to change, British Journal of Psychiatry, 134, 382, 10.1192/bjp.134.4.382 · DOI · Paper page
  24. Schulz, 1995, Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA, 273, 408, 10.1001/jama.1995.03520290060030 · DOI
  25. Spitzer, 1978, Research diagnostic criteria: rationale and reliability, Archives of General Psychiatry, 35, 773, 10.1001/archpsyc.1978.01770300115013 · DOI · Paper page
  26. Ware, 1993, SF-36 Health SurveyManual and Interpetation Guide
  27. 1978, The Ninth Revision of the International Classification of Diseases and Related Health Problems (ICD-9)
  28. 1992, International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10)
  29. 2005, The European Health Report 2005
  30. Wing, 1994, Measuring mental health outcomes: a perspective from the Royal College of Psychiatrists

Cited by

See all 53

Metadata

Authors
Leucht, C., Huhn, M., & Leucht, S.
Venue
Cochrane Database of Systematic Reviews
Published
2011-05-11
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4235822517
Cited by
53
References
9
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amitriptyline versus placebo for major depressive disorder. https://app.cochat.ai/papers/10.1002/14651858.cd009138
The paper
Leucht, C., Huhn, M., & Leucht, S. (2011). Amitriptyline versus placebo for major depressive disorder. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd009138

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.